2023年至2028年电子处方笺市场预测
市场调查报告书
商品编码
1410025

2023年至2028年电子处方笺市场预测

E-Prescribing Market - Forecasts from 2023 to 2028

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 150 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计电子处方笺市场在预测期内将以 17.49% 的复合年增长率成长。

电子处方笺市场的成长正在迅速扩大,并且预计很快就会发生。先进医疗服务创新的广泛使用、政府估计对电子健康记录(EHR) 的支持以及对解决药物安全和患者治疗结果的渴望正在推动这一发展。电子处方笺市场规模受到医疗机构对电子处方笺系统和解决方案的需求的影响。市场参与企业的电子处方笺市场占有率庞大,这增加了电子推荐市场的竞争力和活力。随着医疗保健产业拥抱数位转型,电子处方笺市场的成长有望持续成长和创新。

介绍

由于先进医疗服务解决方案的使用越来越多,电子处方笺市场规模正在经历重大转折和变化。电子处方笺是在医疗服务专业人员和药局之间以电子方式传输和交付治疗药物订单的系统。电子处方笺消除了对传统纸本解决方案的需求,并具有提高用药准确性、提高病患安全性和加快工作速度等优点。

随着医疗保健服务协会和供应商意识到从纸本解决方案转向电子框架的好处,电子处方笺市场迅速增长。电子处方笺预计将在医疗服务数位化中发挥基础性作用,并有可能提高医疗保健理解、减少治疗错误并提高医疗保健熟练程度。

电子处方笺市场的主要企业

  • Epic Systems Corporation: Epic 是着名的 EHR 框架提供者,其电子处方笺模组允许医疗专业人员以电子方式向药局提交药物。该模组旨在与其他令人惊嘆的 EHR 元素结合使用,为管理人员提供高效的药物和准确的支援。
  • DrFirst Inc: DrFirst 是电子建议和安全通讯管理领域的重要权威。该公司的 Rcopia 创新提供电子处方、药物历史管理和药物妥协设备,帮助医疗保健专业人员驾驭治疗週期并了解安全性。
  • Surescripts管理全国最大的医疗资讯组织。除了提供电子处方笺外,我们还建立了一个全国性组织,作为医疗专业人员和药局之间的接口,允许电子处方笺的移动和药物历史的访问。
  • Cerner Corporation Cerner Organization 是健康服务资料创新领域的市场领导者。该公司提供电子健康记录(EHR) 框架和相关的电子处方处方笺,使卫生服务临床医生能够以电子方式提供和提交治疗、访问用药历史和升级药物。我是。

市场驱动因素:

市场驱动因素:电子病历采用率的提高和医疗数位化倡议:

普及医疗保健数位化措施和电子健康记录(EHR) 的日益普及,对电子处方笺方案的需求不断增加。这项需求是由提高病患安全、简化业务流程和进一步提高经营团队效率的愿望所推动的。

进一步提升电子处方笺的成本和有效性优势:

电子处方笺框架透过消除文书工作、减少药物失败和加快治疗週期来释放现金和时间。这使得医疗保健提供者能够利用电子处方笺的进步来改善患者的治疗结果并增强业务。

科技的发展:

多功能应用程式和云端基础的平台等医疗保健创新的推动将推动电子处方笺市场向前发展。这些创新可以与现有的卫生服务框架保持一致的联繫,进一步发展开放性,并为卫生服务专业人员和患者提供持续的解决方案资料。

预计电子处方笺市场将在预测期内稳定成长。

电子处方笺市场按产品、交付型态、最终用户和地区进行细分。产品进一步细分为服务和解决方案。交付型态进一步分为本地、云端基础和基于网路。

北美预计将引领全球电子处方笺市场。

北美是电子处方笺市场的领导者,在电子处方笺市场中占有重要份额。该地区的主导地位有几个原因。首先,成熟的医疗保健基础设施和现代医疗保健 IT 系统正在推动电子处方笺解决方案的普及。其次,鼓励使用电子健康记录(EHR)和数位处方笺的政府倡议和法律正在刺激产业扩张。此外,医疗保健专业人员和患者对电子处方笺益处的广泛认可也促进了处方笺在北美的广泛接受。由于该领域的主要竞争对手和联盟/合作伙伴关係,北美在电子处方笺市场的市场地位正在提高。

主要进展:

2023 年 6 月,Telecare 宣布推出澳洲首个独立电子处方笺平台 RxPad。云端基础的平台允许医疗保健专业人员编写处方笺,而无需将其输入实践管理软体,从而进一步改善了查看和编辑患者处方笺。 2023 年 1 月标誌着 Pharmacy Data 的推出,这是互通性平台和健康资讯网路 (HIN) 公司 Health Gorilla 推出的新解决方案,可让大多数主要药房轻鬆存取全面的处方历史资料。 DrFirst 的 MedHx 人口风险管理 (PRM) 系统为药房资料提供支持,提供来自区域和国家资料来源的重复处方历史记录,例如处方资料、药房配药资料和药房福利管理申请。

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表

第二章调查方法

  • 调查资料
  • 先决条件

第三章执行摘要

  • 研究亮点

第四章市场动态

  • 市场驱动因素
  • 市场抑制因素
  • 波特五力分析
  • 产业价值链分析

第五章电子处方笺市场:分产品

  • 介绍
  • 解决方案
  • 服务

第六章 电子处方笺市场:依交付模式

  • 介绍
  • 基于网路的
  • 本地
  • 云端基础

第 7 章 电子处方笺市场:依最终使用者划分

  • 介绍
  • 医院
  • 医生检查室
  • 药局

第八章电子处方笺市场:按地区

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 其他的
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 印尼
    • 台湾
    • 其他的

第九章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作

第十章 公司简介

  • Cerner Corporation
  • Veradigm LLC(Formerly AllScripts)
  • athenahealth
  • NextGen Healthcare, Inc.
  • McKesson Corporation
  • Practice Fusion, Inc.(acquired by Veradigm LLC)
  • Surescripts LLC
  • DrFirst
  • Medical Information Technology, Inc.(MEDITECH)
简介目录
Product Code: KSI061615677

The E-Prescribing market is estimated to grow at a CAGR of 17.49% during the forecast period.

The E-Prescribing market growth is expanding quickly and is supposed to do so sooner rather than later. The expanded use of advanced medical services innovations, government estimates supporting electronic health records (EHRs), and the craving to work on drug security and patient results are driving this development. The E-Prescribing market size is influenced by healthcare organizations' requirements for E-Prescribing systems and solutions. The market's significant participants have huge E-Prescribing market shares, which adds to the general competitiveness and dynamism of the E-Recommending market. As the healthcare sector embraces digital transformation, the e-prescription market growth is poised for ongoing growth and innovation.

Introduction:

Due to the expanded utilization of advanced medical services solutions, the E-Prescribing market size is seeing a significant turn of events and change. The course of electronically delivering and conveying remedy orders between medical services professionals and drug stores is known as e-prescribing. It takes out the requirement for customary paper-based solutions, bringing about a few benefits like expanded drug precision, more noteworthy patient security, and quicker tasks.

The E-Prescribing market growth is growing quickly as medical services associations and suppliers see the advantages of moving from paper-based solutions to electronic frameworks. E-prescribing is ready to assume a basic part in the computerized unrest of medical services, with the possibility to work on understanding healthcare, limit remedy slip-ups, and increment by and large healthcare proficiency.

Key Players in the E-Prescribing Market:

  • Epic Systems Corporation: Epic is a notable EHR framework provider, and its E-Prescribing module empowers medical care specialists to submit remedies to drug stores electronically. The module is intended to work couple with other Awe-inspiring EHR elements to give productive medication to the executives and exact endorsing.
  • DrFirst Inc.: DrFirst represents considerable authority in electronic recommending and secure correspondence administration. Their Rcopia innovation gives electronic prescribing, medicine history administrations, and drug compromise devices, helping medical care specialists advance the remedy cycle and work on understanding security.
  • Surescripts: Surescripts deals with the country's biggest health information organization. They give E-Prescribing administrations, as well as a countrywide organization that interfaces medical care professionals and drug stores, considering electronic prescription moves and medicine history access.
  • Cerner Corporation: Cerner Organization is a market chief in medical services data innovation. They give E-Prescribing arrangements that are associated with their electronic health records (EHR) frameworks, permitting medical services clinicians to deliver and submit remedies electronically, access medicine chronicles, and upgrade drug the board.

MARKET DRIVERS:

Increasing Adoption of EHRs and healthcare digitalization initiatives to boost the market:

E-prescribing solutions are in high demand as healthcare digitalization initiatives and electronic health records (EHRs) gain traction. The longing to increase patient security, smooth out work processes, and further develop drug the executive's productivity is driving this reception.

Cost and effectiveness benefits to further fuel the e-prescribing:

E-prescribing frameworks set aside cash and time by disposing of desk work, decreasing drug botches, and speeding up the remedy cycle. This spurs medical care suppliers to send E-Prescribing advances to improve patient results and upgrade their tasks.

Technological Advancements:

Propels in healthcare innovation, including versatile applications and cloud-based stages, help to drive the E-Prescribing market forward. These innovations take into consideration consistent association with existing medical services frameworks, further developed openness, and constant solution data for both medical services experts and patients.

The e-prescribing market is anticipated to grow at a steady rate in the forecast period.

The market for e-prescribing is segmented by product, delivery mode, end-user, and geography. The product is further segmented into services and solutions. Delivery mode is further segmented into on-premises, cloud-based, and web-based.

North America is expected to be a leading e-prescribing marketplace globally.

North America is the market leader in E-Prescribing, with a significant e-prescribing market share. Several reasons contribute to the region's prominence. For starters, the availability of established healthcare infrastructure and modern healthcare IT systems has aided E-Prescribing solution uptake. Second, government initiatives and legislation encouraging the use of electronic health records (EHRs) and digital prescriptions have spurred industry expansion. Furthermore, a great awareness of the benefits of E-Prescribing among healthcare practitioners and patients has helped to its broad acceptance in North America. Major competitors in the area, as well as alliances and partnerships, have enhanced North America's market position in the E-Prescribing market.

Key Developments:

  • In June 2023, Telecare launched Australia's first stand-alone e-prescription platform namely "RxPad" which is compliant with Australian Digital Health Agency guidelines. The cloud-based platform enables medical professionals to write off prescriptions without entering into any practice management software and further increases their access to view and edit patient's prescriptions.
  • In January 2023, Pharmacy Data is a new solution from Health Gorilla, a leading interoperability platform and Health Information Network (HIN), that makes it simple to access comprehensive prescription history data from most major pharmacies. DrFirst's MedHx Population Risk Management (PRM) system is the driving force behind Pharmacy Data, which delivers deduplicated prescription history from local and national data sources like prescribing data, pharmacy dispensing data, and pharmacy benefits management claims.

Segmentation

BY PRODUCT

  • Solutions
  • Services

BY DELIVERY MODE

  • Web-based
  • On-premise
  • Cloud-based

BY END-USER

  • Hospitals
  • Physician Offices
  • Pharmacies

BY Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Taiwan
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

  • 2.1. Research Data
  • 2.2. Assumptions

3. EXECUTIVE SUMMARY

  • 3.1. Research Highlights

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Force Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. E-PRESCRIBING MARKET, BY PRODUCT

  • 5.1. Introduction
  • 5.2. Solutions
  • 5.3. Services

6. E-PRESCRIBING MARKET, BY DELIVERY MODE

  • 6.1. Introduction
  • 6.2. Web-based
  • 6.3. On-premises
  • 6.4. Cloud-based

7. E-PRESCRIBING MARKET, BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Physician Offices
  • 7.4. Pharmacies

8. E-PRESCRIBING MARKET, BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. United States
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. United Kingdom
    • 8.4.2. Germany
    • 8.4.3. France
    • 8.4.4. Italy
    • 8.4.5. Spain
    • 8.4.6. Others
  • 8.5. The Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. Japan
    • 8.6.2. China
    • 8.6.3. India
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Taiwan
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations

10. COMPANY PROFILES

  • 10.1. Cerner Corporation
  • 10.2. Veradigm LLC (Formerly AllScripts)
  • 10.3. athenahealth
  • 10.4. NextGen Healthcare, Inc.
  • 10.5. McKesson Corporation
  • 10.6. Practice Fusion, Inc. (acquired by Veradigm LLC)
  • 10.7. Surescripts LLC
  • 10.8. DrFirst
  • 10.9. Medical Information Technology, Inc. (MEDITECH)